Oxygen Biotherapeutics Announces $6M in Net Proceeds from Exercise of Warrants

By: Benzinga
Oxygen Biotherapeutics (NASDAQ: OXBT ) today announced the Company has received approximately $6 million through the exercise of 2,294,874 warrants between November 4, 2013 and November 6, 2013.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.